LONDON, April 17 (Reuters) – ”Drugmaker GlaxoSmithKline – hit by bribery claims in five countries – is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.
Following a decision to cut commercial ties with outside doctors, GSK expects to increase its in-house team of physicians by 10-20 percent over the next year or so from around 1,500 at present, Chief Medical Officer James Shannon told Reuters.
Leaders of Britain's biggest drugmaker believe they have a blueprint that will put GSK ahead of rivals when it comes to ethical behaviour – but the company keeps getting knocked back by allegations of past corrupt practices.
GSK is now investigating claims that bribes were paid to doctors in Poland, Iraq, Jordan and Lebanon, following a much larger case of alleged bribery in China.
Chinese authorities in July accused GSK of funnelling up to 3 billion yuan ($483 million) to doctors and officials to encourage them to use its medicines in a case that the company has described as shameful. ….
Contd http://in.reuters.com/article/2014/04/17/gsk-corruption-idINL6N0N71OD20140417
The Board Director Training Institute (BDTI) is a "public interest" nonprofit in Japan dedicated to training about directorship, corporate governance, and related management techniques. It is certified by the Japanese government to conduct these activities as a regulated nonprofit. Read a summary about BDTI here, and see a menu of its services for both corporations and investors here.